|
FOXO3B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.905600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.048000E-01 |
| Normal-vs-Stage2 |
7.806000E-02 |
| Normal-vs-Stage3 |
1.907890E-02 |
| Normal-vs-Stage4 |
7.564000E-03 |
| Stage1-vs-Stage2 |
1.716120E-02 |
| Stage1-vs-Stage3 |
1.319350E-03 |
| Stage1-vs-Stage4 |
6.425700E-04 |
| Stage2-vs-Stage3 |
9.939600E-01 |
| Stage2-vs-Stage4 |
6.076400E-01 |
| Stage3-vs-Stage4 |
5.237000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.894600E-01 |
| Normal-vs-AfricanAmerican |
6.756800E-01 |
| Normal-vs-Asian |
9.088600E-01 |
| Caucasian-vs-AfricanAmerican |
2.042600E-01 |
| Caucasian-vs-Asian |
6.633800E-01 |
| AfricanAmerican-vs-Asian |
9.485800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.311400E-01 |
| Normal-vs-Female |
5.990400E-01 |
| Male-vs-Female |
5.429800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.774600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.358800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.034590E-01 |
| Normal-vs-Age(81-100Yrs) |
1.634130E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.409200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.411400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.435770E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.114760E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.015370E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.655600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.286250E-02 |
| Normal-vs-Grade 2 |
3.812000E-01 |
| Normal-vs-Grade 3 |
3.021700E-02 |
| Normal-vs-Grade 4 |
7.623600E-04 |
| Grade 1-vs-Grade 2 |
6.024100E-03 |
| Grade 1-vs-Grade 3 |
4.47940000000147E-05 |
| Grade 1-vs-Grade 4 |
1.28820000000474E-06 |
| Grade 2-vs-Grade 3 |
1.781060E-03 |
| Grade 2-vs-Grade 4 |
3.88209999999667E-05 |
| Grade 3-vs-Grade 4 |
1.057780E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.161770E-01 |
| Normal-vs-ccB subtype |
7.882500E-03 |
| ccA subtype-vs-ccB subtype |
3.86060000000521E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.037800E-01 |
| Normal-vs-N1 |
5.458900E-03 |
| N0-vs-N1 |
8.895500E-02 |
|
|
